Australia and New Zealand survey of glaucoma practice patterns

Clinical and Experimental Ophthalmology

Volumn 36, Issue 1, 2008, Pages 19-25

  Liu, Lance ^a,b  

^a ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

^b Preston Eye Clinic   (Australia)

Author keywords

Central corneal thickness; Glaucoma survey; Gonioscopy; Intraocular pressure; Optic disc

Indexed keywords

ANTIMETABOLITE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROSTAGLANDIN DERIVATIVE; STEROID;

ARTICLE; AUSTRALIA; CLINICAL PRACTICE; CORNEA THICKNESS; EYE CARE; EYE EXAMINATION; GEOGRAPHIC OPHTHALMOLOGY; GLAUCOMA; GONIOSCOPY; HUMAN; INTRAOCULAR PRESSURE; MEDICAL EXPERT; MEDICAL SPECIALIST; NEW ZEALAND; OPTIC DISK; OPTIC NERVE DISEASE; PRESSURE MEASUREMENT; PROFESSIONAL KNOWLEDGE; TRABECULOPLASTY; VISUAL SYSTEM EXAMINATION;

AUSTRALIA; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; DOCUMENTATION; FOLLOW-UP STUDIES; GLAUCOMA; GONIOSCOPY; HEALTH PERSONNEL; HUMANS; INTRAOCULAR PRESSURE; LASER THERAPY; MANOMETRY; NEW ZEALAND; OPHTHALMOLOGY; OPTIC DISK; ORTHOPTICS; PHYSICIAN'S PRACTICE PATTERNS; PROSTAGLANDINS; QUESTIONNAIRES; TRABECULECTOMY;

EID: 39649088001     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2007.01623.x     Document Type: Article

References (46)

1. EGS. Terminology and Guidelines for Glaucoma, 2nd edn. Savona: Dogma, 2003.
2. AAO. Primary Open-Angle Glaucoma, Preferred Practice Pattern. San Francisco, CA: American Academy of Ophthalmology, 2005.
3. AAO. Primary Angle Closure, Preferred Practice Pattern. San Francisco, CA: American Academy of Ophthalmology, 2005.
4. SEAGIG. Asia Pacific Glaucoma Guidelines. Singapore, SEAGIG, 2003-2004.
5. Fremont AM, Lee PP, Mangione CM etal. Patterns of care for open-angle glaucoma in managed care. Arch Ophthalmol 2003; 121: 777-83.
6. Albrecht KG, Lee PP. Conformance with preferred practice patterns in caring for patients with glaucoma. Ophthalmology 1994; 101: 1668-71.
7. Hertzog LH, Albrecht KG, LaBree L, Lee PP. Glaucoma care and conformance with preferred practice patterns. Examination of the private, community-based ophthalmologist. Ophthalmology 1996; 103: 1009-13.
8. Gaskin BJ, Carroll SC, Gamble G, Goldberg I, Danesh-Meyer HV. Glaucoma management trends in Australia and New Zealand. Clin Experiment Ophthalmol 2006; 34: 208-12.
9. Spaeth GL, Henderer J, Liu C et al. The disc damage likelihood scale: reproducibility of a new method of estimating the amount of optic nerve damage caused by glaucoma. Trans Am Ophthalmol Soc 2002; 100: 181-5; Discussion 185-6.
10. Tonnu PA, Ho T, Sharma K, White E, Bunce C, Garway-Heath D. A comparison of four methods of tonometry: Method agreement and interobserver variability. Br J Ophthalmol 2005; 89: 847-50.
11. Horowitz GS, Byles J, Lee J, D'Este C. Comparison of the Tono-Pen and Goldmann tonometer for measuring intraocular pressure in patients with glaucoma. Clin Experiment Ophthalmol 2004; 32: 584-9.
12. Barkana Y, Anis S, Liebmann J, Tello C, Ritch R. Clinical utility of intraocular pressure monitoring outside of normal office hours in patients with glaucoma. Arch Ophthalmol 2006; 124: 793-7.
13. Asrani S, Zeimer R, Wilensky J, Gieser D, Vitale S, Lindenmuth K. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma 2000; 9: 134-42.
14. Bengtsson B, Leske MC, Hyman L, Heijl A. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Ophthalmology 2007; 114: 205-9.
15. Doughty MJ, Zaman ML. Human corneal thickness and its impact on intraocular pressure measures. a review and meta-analysis approach. Surv Ophthalmol 2000; 44: 367-408.
16. Goldmann H, Schmidt T. [Applanation tonometry.]Ophthalmologica 1957; 134: 221-42.
17. Gordon MO, Beiser JA, Brandt JD et al. The ocular hypertension treatment study: Baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002; 120: 714-20; Discussion 829-30.
18. Medeiros FA, Sample PA, Zangwill LM, Bowd C, Aihara M, Weinreb RN. Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy. Am J Ophthalmol 2003; 136: 805-13.
19. Herndon LW, Weizer JS, Stinnett SS. Central corneal thickness as a risk factor for advanced glaucoma damage. Arch Ophthalmol 2004; 122: 17-21.
20. Hewitt AW, Cooper RL. Relationship between corneal thickness and optic disc damage in glaucoma. Clin Experiment Ophthalmol 2005; 33: 158-63.
21. Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore eye survey. JAMA 1991; 266: 369-74.
22. Mitchell P, Smith W, Attebo K, Healey PR. Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology 1996; 103: 1661-9.
23. Foster PJ, Baasanhu J, Alsbirk PH, Munkhbayar D, Uranchimeg D, Johnson GJ. Glaucoma in Mongolia. A population-based survey in Hovsgol province, northern Mongolia. Arch Ophthalmol 1996; 114: 1235-41.
24. Quigley HA. Dirty little secrets. Clin Experiment Ophthalmol 2006; 34: 195-6.
25. Liu L. Physiological changes of the angle with anterior segment OCT. British J Ophthal Video Website, February 2007. Available from: http://bjo.bmj.com/cgi/content/full/88/11/DC1/1
26. Gazzard G, Foster P, Friedman D, Khaw P, Seah S. Light to dark physiological variation in irido-trabecular angle width. Br J Ophthalmol Video Website, November 2004. Available from: http://bjo.bmj.com/cgi/ content/full/91/2/DC2/1
27. Foster P, He M, Liebmann J. Epidemiology, classification and mechanism. In: Weinreb R & Friedman D, eds. Angle Closure and Angle Closure Glaucoma-Consensus Series 3. The Hague: Kugler Publications, 2006; 1-20.
28. Liu L. Development of the Anterior Chamber. In: Weinreb RN, Friedman DS, eds. Angle Closure and Angle Closure Glaucoma-Consensus Series 3. The Hague: Kugler Publications, 2006; 65-9.
29. Ochiai H, Chihara E, Chuman H, Sawada A, Akita J. Age and increased incidence of 'forward bowing'of the iris in normal eyes. J Glaucoma 1998; 7: 408-12.
30. Duncan G, Wormstone IM, Davies PD. The aging human lens: Structure, growth, and physiological behaviour. Br J Ophthalmol 1997; 81: 818-23.
31. Foster PJ, Buhrmann R, Quigley HA, Johnson GJ. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol 2002; 86: 238-42.
32. Weinreb RN, Greve EL. Glaucoma Diagnosis-Structure and Function. The Hague: Kugler Publications, 2004.
33. Kamal DS, Garway-Heath DF, Hitchings RA, Fitzke FW. Use of sequential Heidelberg retina tomograph images to identify changes at the optic disc in ocular hypertensive patients at risk of developing glaucoma. Br J Ophthalmol 2000; 84: 993-8.
34. Chauhan BC, McCormick TA, Nicolela MT, LeBlanc RP. Optic disc and visual field changes in a prospective longitudinal study of patients with glaucoma: Comparison of scanning laser tomography with conventional perimetry and optic disc photography. Arch Ophthalmol 2001; 119: 1492-9.
35. Tielsch JM, Katz J, Quigley HA, Miller NR, Sommer A. Intraobserver and interobserver agreement in measurement of optic disc characteristics. Ophthalmology 1988; 95: 350-6.
36. Zeyen T, Miglior S, Pfeiffer N, Cunha-Vaz J, Adamsons I. Reproducibility of evaluation of optic disc change for glaucoma with stereo optic disc photographs. Ophthalmology 2003; 110: 340-4.
37. Kerrigan-Baumrind LA, Quigley HA, Pease ME, Kerrigan DF, Mitchell RS. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest Ophthalmol Vis Sci 2000; 41: 741-8.
38. Shah NN, Bowd C, Medeiros FA et al. Combining structural and functional testing for detection of glaucoma. Ophthalmology 2006; 113: 1593-602.
39. Walland MJ. Glaucoma treatment in Australia. changing patterns of therapy 1994-2003. Clin Experiment Ophthalmol 2004; 32: 590-6.
40. Diggory P, Cassels-Brown A, Vail A, Abbey LM, Hillman JS. Avoiding unsuspected respiratory side-effects of topical timolol with cardioselective or sympathomimetic agents. Lancet 1995; 345: 1604-6.
41. Carroll SC, Gaskin BJ, Goldberg I, Danesh-Meyer HV. Glaucoma prescribing trends in Australia and New Zealand. Clin Experiment Ophthalmol 2006; 34: 213-8.
42. Albright CD, Schuman SG, Netland PA. Usage and cost of laser trabeculoplasty in the United States. Ophthalmic Surg Lasers 2002; 33: 334-6.
43. Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT) and glaucoma laser trial follow-up study: 7. Results. Am J Ophthalmol 1995; 120: 718-31.
44. Johnstone MA, Shingleton BJ, Crandall AS, Brown RH, Robin AL. Glaucoma surgery treatment patterns of ASCRS members - 2000 survey. J Cataract Refract Surg 2001; 27: 1864-71.
45. Joshi AB, Parrish RK, 2nd, Feuer WF. 2002 survey of theAmerican Glaucoma Society: Practice preferences for glaucoma surgery and antifibrotic use. J Glaucoma 2005; 14: 172-4.
46. Gore-Felton C, Koopman C, Bridges E, Thoresen C, Spiegel D. An example of maximizing survey return rates. Methodological issues for health professionals. Eval Health Prof 2002; 25: 152-68.